Abbott Laboratories (ABT)

Cost of Revenue

$5.29B

Quarterly · Period ending: · USD

ABT logo

ABT Cost of Revenue

Latest reported$5.29B
ABT Quarterly Cost of Revenue ($0.00 → $5.29B)
High-resolution chart · PNG

ABT cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Abbott Laboratories Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
5,289,000,000
4,881,000,000
4,922,000,000
5,031,000,000
4,854,000,000
4,914,000,000
5,376,000,000
5,209,000,000
5,072,000,000
4,942,000,000
4,983,000,000
5,109,000,000
5,033,000,000
4,942,000,000
5,120,000,000
5,201,000,000
5,483,000,000
5,526,000,000
5,259,000,000
4,868,000,000
4,848,000,000
4,886,000,000
5,014,000,000
4,521,000,000
3,847,000,000
3,849,000,000
3,931,000,000
3,866,000,000
3,779,000,000
3,645,000,000
3,682,000,000
3,672,000,000
3,790,000,000
3,611,000,000
3,808,000,000
3,351,000,000
3,579,000,000
3,561,000,000
2,416,000,000
2,430,000,000
2,287,000,000
2,140,000,000
2,206,000,000
2,242,000,000
2,218,000,000
2,081,000,000
2,337,000,000
2,331,000,000
2,506,000,000
2,470,000,000
2,613,000,000
2,450,000,000
2,545,000,000
2,432,000,000
4,059,410,000
3,698,000,000
3,637,000,000
3,725,000,000
3,837,875,000
3,973,000,000
3,870,000,000
3,859,000,000
4,045,040,000
3,742,000,000
3,544,000,000
3,335,000,000
3,784,223,000
3,360,000,000
3,129,000,000
2,935,921,000
3,178,381,000
3,352,869,000
3,119,700,000
2,961,072,000
3,161,680,000
2,864,030,000
2,804,326,000
2,176,695,000
2,865,612,000
2,391,218,000
2,388,613,000
2,169,704,000
2,809,557,000
2,677,188,000
2,631,835,000
2,522,531,000
2,627,094,000
2,114,919,000
2,068,722,000
2,480,281,000
2,658,013,000
2,346,807,000
2,270,855,000
2,197,741,000
2,376,093,000
2,067,494,000
2,166,590,000
1,896,077,000
2,081,101,000
2,040,899,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.